Search research articles
Contact Us
Filters
Showing results (41-50 of 86) with videos related to
Page
of 9
Sort By:
International Journal of Molecular Sciences
|
April 20, 2016
Prognostic Value of MicroRNAs in Preoperative Treated Rectal Cancer
Azadeh Azizian, Ingo Epping, Frank Kramer, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 26, 2010
A gene expression signature for chemoradiosensitivity of colorectal cancer cells
Melanie Spitzner, Georg Emons, Frank Kramer, et al.
Genes, Chromosomes & Cancer
|
August 21, 2010
Mutated KRAS results in overexpression of DUSP4, a MAP-kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomas
Jochen Gaedcke, Marian Grade, Klaus Jung, et al.
Cancer Research
|
January 11, 2007
Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas
Marian Grade, Patrick Hörmann, Sandra Becker, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 13, 2013
Identification of a microRNA expression signature for chemoradiosensitivity of colorectal cancer cells, involving miRNAs-320a, -224, -132 and let7g
Junius Salendo, Melanie Spitzner, Frank Kramer, et al.
Cancers
|
August 14, 2025
FLOT Versus CROSS-What Is the Optimal Therapeutic Approach for Locally Advanced Adenocarcinoma of the Esophagus and the Esophagogastric Junction?
Martin Leu, Hannes Mahler, Johanna Reinecke, et al.
International Journal of Molecular Sciences
|
November 11, 2020
TIM-3 Genetic Variants Are Associated with Altered Clinical Outcome and Susceptibility to Gram-Positive Infections in Patients with Sepsis
Caspar Mewes, Tessa Alexander, Benedikt Büttner, et al.
EMBO Reports
|
October 7, 2018
Loss of <i>CHD1</i> causes DNA repair defects and enhances prostate cancer therapeutic responsiveness
Vijayalakshmi Kari, Wael Yassin Mansour, Sanjay Kumar Raul, et al.
Zentralblatt Fur Chirurgie
|
February 10, 2026
[The GeRMIQ-Curriculum: a Blueprint for a National Training Concept in Minimally Invasive and Robotic Surgery]
Tobias Huber, Sven Flemming, Jessica Stockheim, et al.
EMBO Reports
|
September 7, 2016
Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsiveness
Vijayalakshmi Kari, Wael Yassin Mansour, Sanjay Kumar Raul, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 86) with videos related to
Sort By:
Page
of 9
International Journal of Molecular Sciences
|
April 20, 2016
Prognostic Value of MicroRNAs in Preoperative Treated Rectal Cancer
Azadeh Azizian, Ingo Epping, Frank Kramer, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 26, 2010
A gene expression signature for chemoradiosensitivity of colorectal cancer cells
Melanie Spitzner, Georg Emons, Frank Kramer, et al.
Genes, Chromosomes & Cancer
|
August 21, 2010
Mutated KRAS results in overexpression of DUSP4, a MAP-kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomas
Jochen Gaedcke, Marian Grade, Klaus Jung, et al.
Cancer Research
|
January 11, 2007
Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas
Marian Grade, Patrick Hörmann, Sandra Becker, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 13, 2013
Identification of a microRNA expression signature for chemoradiosensitivity of colorectal cancer cells, involving miRNAs-320a, -224, -132 and let7g
Junius Salendo, Melanie Spitzner, Frank Kramer, et al.
Cancers
|
August 14, 2025
FLOT Versus CROSS-What Is the Optimal Therapeutic Approach for Locally Advanced Adenocarcinoma of the Esophagus and the Esophagogastric Junction?
Martin Leu, Hannes Mahler, Johanna Reinecke, et al.
International Journal of Molecular Sciences
|
November 11, 2020
TIM-3 Genetic Variants Are Associated with Altered Clinical Outcome and Susceptibility to Gram-Positive Infections in Patients with Sepsis
Caspar Mewes, Tessa Alexander, Benedikt Büttner, et al.
EMBO Reports
|
October 7, 2018
Loss of <i>CHD1</i> causes DNA repair defects and enhances prostate cancer therapeutic responsiveness
Vijayalakshmi Kari, Wael Yassin Mansour, Sanjay Kumar Raul, et al.
Zentralblatt Fur Chirurgie
|
February 10, 2026
[The GeRMIQ-Curriculum: a Blueprint for a National Training Concept in Minimally Invasive and Robotic Surgery]
Tobias Huber, Sven Flemming, Jessica Stockheim, et al.
EMBO Reports
|
September 7, 2016
Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsiveness
Vijayalakshmi Kari, Wael Yassin Mansour, Sanjay Kumar Raul, et al.
Page
of 9